R&D Navigating geopolitical risks: Practical and legal mitigatio... Geopolitical risk is now front of mind for many pharmaceutical leaders.
Patients Reshaping the future of patient-centric drug development Strategic partnerships, robust quality systems, and manufacturing know-how will support next-generation therapies with patient-centric designs.
R&D Why critical-care injectables are among the hardest medicine... When hospitals in the United States began delaying elective procedures in 2024 over a shortage of intravenous saline solutions, it exposed a structural vulnerability that rarely makes headl
R&D From pilots to patients: Why the UK must rethink NHS innovat... At PharmaTech Integrates in Glasgow, speakers from government, academia, the NHS, and pharma sought to define the sector’s path forward.
R&D The UK can’t just be a life sciences lab – we need manufactu... Rachel Reeves is right: the UK is at the forefront of life sciences, with some world-leading research and innovation.
Oncology On looking to a future multiomics approach for CDx, with Jan... The pharmaphorum podcast caught up with Jane Li, VP and general manager for companion diagnostics at Thermo Fisher Scientific, following ESMO 2026.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.